
This paper establishes a framework for understanding the complex relationships between zzso zzso markers of resistance to zzso drugs and clinical measures of disease zzso A new zzso scheme based on the probabilities of how new patients will respond to zzso therapy given the available data is proposed as a method for distinguishing among groups of viral zzso This approach draws from existing cluster analysis, zzso analysis, and zzso zzso techniques and requires a model relating zzso characteristics to zzso zzso A data set of zzso sequences and the corresponding zzso 50% zzso zzso are described and used for illustrative zzso 

